Effect of azithromycin on incidence of acute respiratory exacerbations in children with HIV taking antiretroviral therapy and co-morbid chronic lung disease: a secondary analysis of the BREATHE trial

Effect of azithromycin on incidence of acute respiratory exacerbations in children with HIV taking antiretroviral therapy and co-morbid chronic lung disease: a secondary analysis of the BREATHE trial

Background: In the BREATHE trial weekly azithromycin decreased the rate of acute respiratory exacerbations (AREs) compared to placebo among children and adolescents with HIV-associated chronic lung disease (CLD) taking antiretroviral therapy (ART). The aim of this analysis was to identify risk facto...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amy Price, Grace McHugh, Victoria Simms, Robina Semphere, Lucky G Ngwira, Tsitsi Bandason, Hilda Mujuru, Jon O Odland, Rashida A Ferrand, Andrea M Rehman
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/d03ae235e3c244d9a0cdbd7a1abb0876
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares